Feemster, K.; Hausdorff, W.P.; Banniettis, N.; Platt, H.; Velentgas, P.; Esteves-Jaramillo, A.; Burton, R.L.; Nahm, M.H.; Buchwald, U.K.
Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974. Vaccines 2025, 13, 831.
https://doi.org/10.3390/vaccines13080831
AMA Style
Feemster K, Hausdorff WP, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A, Burton RL, Nahm MH, Buchwald UK.
Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974. Vaccines. 2025; 13(8):831.
https://doi.org/10.3390/vaccines13080831
Chicago/Turabian Style
Feemster, Kristen, William P. Hausdorff, Natalie Banniettis, Heather Platt, Priscilla Velentgas, Alejandra Esteves-Jaramillo, Robert L. Burton, Moon H. Nahm, and Ulrike K. Buchwald.
2025. "Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974" Vaccines 13, no. 8: 831.
https://doi.org/10.3390/vaccines13080831
APA Style
Feemster, K., Hausdorff, W. P., Banniettis, N., Platt, H., Velentgas, P., Esteves-Jaramillo, A., Burton, R. L., Nahm, M. H., & Buchwald, U. K.
(2025). Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974. Vaccines, 13(8), 831.
https://doi.org/10.3390/vaccines13080831
